Search Page

1

Cite

Share

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.

Llovet JM, Villanueva A, Marrero JA, Schwartz M, Meyer T, Galle PR, Lencioni R, Greten TF, Kudo M, Mandrekar SJ, Zhu AX, Finn RS, Roberts LR; AASLD Panel of Experts on Trial Design in HCC. Llovet JM, et al. Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9. Hepatology. 2021. PMID: 32430997 Review. No abstract available.

Cite

Share

2

Cite

Share

Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.

Runyon BA; AASLD. Runyon BA, et al. Hepatology. 2013 Apr;57(4):1651-3. doi: 10.1002/hep.26359. Hepatology. 2013. PMID: 23463403 No abstract available.

Cite

Share

3

Cite

Share

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

AASLD-IDSA HCV Guidance Panel. AASLD-IDSA HCV Guidance Panel. Clin Infect Dis. 2018 Oct 30;67(10):1477-1492. doi: 10.1093/cid/ciy585. Clin Infect Dis. 2018. PMID: 30215672 Free PMC article.

Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expedi …

Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for t …

Cite

Share

4

Cite

Share

Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD.

Rinella ME, Tacke F, Sanyal AJ, Anstee QM; participants of the AASLD/EASL Workshop. Rinella ME, et al. J Hepatol. 2019 Oct;71(4):823-833. doi: 10.1016/j.jhep.2019.04.019. Epub 2019 Jul 9. J Hepatol. 2019. PMID: 31300231 Review.

Cite

Share

5

Cite

Share

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD.

Rinella ME, Tacke F, Sanyal AJ, Anstee QM; participants of the AASLD/EASL Workshop. Rinella ME, et al. Hepatology. 2019 Oct;70(4):1424-1436. doi: 10.1002/hep.30782. Epub 2019 Jul 9. Hepatology. 2019. PMID: 31287572 Review.

Cite

Share

6

Cite

Share

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference().

Cornberg M, Lok AS, Terrault NA, Zoulim F; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Cornberg M, et al. J Hepatol. 2020 Mar;72(3):539-557. doi: 10.1016/j.jhep.2019.11.003. Epub 2019 Nov 12. J Hepatol. 2020. PMID: 31730789 Free article. Review.

Cite

Share

7

Cite

Share

Management of adult patients with ascites due to cirrhosis: an update.

Runyon BA; AASLD Practice Guidelines Committee. Runyon BA, et al. Hepatology. 2009 Jun;49(6):2087-107. doi: 10.1002/hep.22853. Hepatology. 2009. PMID: 19475696 No abstract available.

Cite

Share

8

Cite

Share

Diagnosis and treatment of Wilson disease: an update.

Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Roberts EA, et al. Hepatology. 2008 Jun;47(6):2089-111. doi: 10.1002/hep.22261. Hepatology. 2008. PMID: 18506894 No abstract available.

Cite

Share

9

Cite

Share

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel. Ghany MG, et al. Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060. Hepatology. 2020. PMID: 31816111 No abstract available.

Cite

Share

10

Cite

Share

Reply.

Chalasani N; Writing Group for the AASLD NAFLD Practice Gudiance. Chalasani N, et al. Hepatology. 2018 Jun;67(6):2478-2479. doi: 10.1002/hep.29841. Epub 2018 Apr 26. Hepatology. 2018. PMID: 29443382 No abstract available.

Cite

Share